Guru Ownership Trend
Guru Analysis for Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics, Inc. (MLYS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $45.41 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $12.32 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 579.5%. Conversely, Louis Moore Bacon reduced exposure by 63.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Mineralys Therapeutics, Inc. (MLYS)
Major holders include Steven Cohen ($43.81 M), Renaissance Technologies (RenTech) ($11.69 M), Cliff Asness ($2.26 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.69 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $12.32 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited MLYS. The total reported sell value was $25.31 M.
Yes, 1 managers opened new positions in MLYS, and 2 increased their existing holdings. The total reported buy value was $12.99 M.